NAS
IONS icon

Nykredit A/S’s Ionis Pharmaceuticals IONS Stock Holding History

Nykredit A/S’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$488K Buy
+6,154
New +$463K ﹤0.01% 698

Other funds holding IONS

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Nykredit A/S's IONS Position: Q2 2026 in Review

Nykredit A/S opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 6,154 shares worth $488K. The stake represents ﹤0.01% of the portfolio and ranks #698 among its holdings.

381 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Nykredit A/S held 6,154 shares of Ionis Pharmaceuticals worth $488K as of Q2 2026.
  • Ionis Pharmaceuticals was a new Nykredit A/S position in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #698 holding.
  • 381 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.